Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor

Johnson, M., Morrison, F. J., McMahon, G., Su, M., & Turchin, A. (2023). Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor. American Heart Journal, 258, 49–59. https://doi.org/10.1016/j.ahj.2023.01.002
Authors:
Matthew Johnson
Fritha J Morrison
Gearoid McMahon
Maxwell Su
Alexander Turchin
Affiliated Authors:
Matthew Johnson
Publication Type:
Article
Unique ID:
10.1016/j.ahj.2023.01.002
PMID:
Publication Date:
Data Source:
PubMed

Record Created: